Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?

Autor: Berchtold J; Dpt. of Radiation Oncology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria., Winkler C; Paracelsus Medical University of Salzburg, Stubergasse 21, 5020, Salzburg, Austria., Karner J; Dpt. of Radiation Oncology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria., Groher M; Dpt. of Radiation Oncology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria., Gaisberger C; Dpt. of Radiation Oncology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria., Sedlmayer F; Dpt. of Radiation Oncology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria., Wolf F; Dpt. of Radiation Oncology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria. f.wolf@salk.at.

Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2024 Mar; Vol. 200 (3), pp. 195-201. Date of Electronic Publication: 2023 Aug 25.

Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.

Autor: Grambozov B; Department of Radiation Oncology, Paracelsus Medical University, SALK, Salzburg, Austria. Electronic address: b.grambozov@salk.at., Kalantari F; Department of Nuclear Medicine, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran; Division of Molecular Imaging and Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria., Beheshti M; Division of Molecular Imaging and Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria., Stana M; Department of Radiation Oncology, Paracelsus Medical University, SALK, Salzburg, Austria., Karner J; Department of Radiation Oncology, Paracelsus Medical University, SALK, Salzburg, Austria., Ruznic E; Department of Radiation Oncology, Paracelsus Medical University, SALK, Salzburg, Austria., Zellinger B; Institute of Pathology, Paracelsus Medical University, SALK, Salzburg, Austria., Sedlmayer F; Department of Radiation Oncology, Paracelsus Medical University, SALK, Salzburg, Austria; radART - Institute for Research and Development on Advanced Radiation Technologies, Paracelsus Medical University, Salzburg, Austria., Rinnerthaler G; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzburg, Austria; Cancer Cluster Salzburg, 5020 Salzburg, Austria., Zehentmayr F; Department of Radiation Oncology, Paracelsus Medical University, SALK, Salzburg, Austria; radART - Institute for Research and Development on Advanced Radiation Technologies, Paracelsus Medical University, Salzburg, Austria.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Aug; Vol. 185, pp. 109728. Date of Electronic Publication: 2023 Jun 09.

Single-cell analysis reveals MHCII expressing keratinocytes in pressure ulcers with worse healing outcomes

Autor: L. Zhang, Maria-Alexandra Toma, Landen Nx, Cheung Y, Qiaolin Deng, Karner J, Pei Y, Pham K, Liv Eidsmo, Shangli Cheng, Dongqing Li, Herter E, Chen X, Sommar P

Pressure ulcer (PU) is a chronic wound often seen in spinal cord injury patients and other bed-bound individuals, particularly in the elderly population. Despite its association with high mortality, the pathophysiology of PU remains poorly understood

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4bce5eb4b301642bde07ce799b67d3f3
https://doi.org/10.1101/2021.04.20.440591

Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL CO Correlate with Radiation Dosimetry and Pneumonitis Rate.

Autor: Stana M; Department of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria., Grambozov B; Department of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria., Karner J; Department of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria., Gollner I; Department of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria., Gaisberger C; Department of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria., Ruznic E; Department of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria., Zellinger B; Institute of Pathology, Paracelsus Medical University, 5020 Salzburg, Austria., Moosbrugger R; Department of Pulmonology, Paracelsus Medical University, 5020 Salzburg, Austria., Studnicka M; Department of Pulmonology, Paracelsus Medical University, 5020 Salzburg, Austria., Fastner G; Department of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria., Sedlmayer F; Department of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria., Zehentmayr F; Department of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria.

Publikováno v: Cancers [Cancers (Basel)] 2023 Mar 25; Vol. 15 (7). Date of Electronic Publication: 2023 Mar 25.